InsiderClue
Stocks · Financials · Blank Checks

Translational Development Acquisition Corp.

TDAC Clue Score35
United States Fiscal year ends December CIK 0001926599
$10.82 +0.06% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $10.82 +4.58% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 13 Feb 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2023Operating income−0.5Net income−0.5Fiscal year 2024Operating income−0.2Net income−0.1Fiscal year 2025Operating income−0.9Net income6.4
FY2023FY2024FY2025
Operating income −0.5 −0.2 −0.9
Net income −0.5 −0.1 6.4
Growth

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2023Operating cash flow−0.0Fiscal year 2024Operating cash flow−0.9Fiscal year 2025Operating cash flow−0.6
FY2023FY2024FY2025
Operating cash flow −0.0 −0.9 −0.6

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2023Cash0.0Shareholders’ equity−0.5Fiscal year 2024Cash0.4Shareholders’ equity−5.6Fiscal year 2025Cash0.0Shareholders’ equity−6.5
FY2023FY2024FY2025
Cash 0.0 0.4 0.0
Shareholders’ equity −0.5 −5.6 −6.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a 0.2 0.9
−0.5 −0.2 −0.9
Growth
n/a 0.0 n/a
−0.5 −0.1 6.4
Growth

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 2 of 3 years on file.